USPTO serial 87474750
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
San Diego, CA, US
San Diego, CA, US
San Diego, CA, US
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents, assays, enzymes, chemical preparations, biological specimens in the nature of human tissue or human body fluid, animal tissue or animal body fluid, cultures of microorganisms, plant tissue and nucleotides for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, clinical research, drug development, drug development research, laboratory research, scientific research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, and genetics, not for medical or veterinary purposes; reagents kits comprised primarily of nucleotides, reagents, enzyme substrates, buffers, chemical preparations, biological preparations in the nature of human tissue or human body fluid, animal tissue or animal body fluid, cultures of microorganisms, plant tissue and enzymes for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, clinical research, drug development, drug development research, laboratory research, scientific and research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, and genetics, not for medical or veterinary purposes | ACTIVE | Jan 9, 2017 |
| 005 | Reagents, clinical diagnostic reagents, medical diagnostic assays for medical and diagnostic purposes, enzymes, nucleotides, buffers, chemical reagents, and biological preparations in the nature of human tissue or human body fluids, animal tissue or animal body fluids, cultures of microorganisms, or plant tissue for medical and veterinary use in the fields of medical diagnostics, veterinary diagnostics, laboratory medicine, veterinary medicine, and genetics | ACTIVE | Jan 9, 2017 |
| 009 | Computer hardware and computer software for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostic research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics; scientific apparatus and instruments, namely, nucleic acid sequencers for laboratory use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics | ACTIVE | Jan 9, 2017 |
| 010 | Clinical and medical diagnostic instruments, namely, nucleic acid sequencers; scientific apparatus and instruments, namely, nucleic acid sequencers for medical and veterinary use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics | ACTIVE | Jan 9, 2017 |
| 042 | Providing on-line non-downloadable computer search engine software; providing online non-downloadable computer software for the custom design and ordering of assays, nucleic acids and reagents; software as a service (Saas), namely, hosting software for use by others for use in the custom design and ordering of assays, nucleic acids and reagents in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostic research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics; Nucleic acid sequencing and analysis services for scientific and research purposes; Genome sequencing and analysis services for scientific and research purposes; genetic analysis and reporting services for scientific and research purposes; installation and maintenance of computer software and database applications for others for use in the fields of nucleic acid sequencing and genotyping, medical diagnostics, clinical diagnostics, medical research, clinical research, life sciences, biology, drug development, drug development research, molecular diagnostics, laboratory medicine, biotechnology, agriculture, forensics, and genetics | ACTIVE | Jan 9, 2017 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 18, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Aug 18, 2026 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Aug 18, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 13, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 29, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 29, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 29, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 29, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 29, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 29, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 22, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 22, 2020 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Sep 22, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 21, 2020 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Aug 20, 2020 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Aug 20, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 20, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 20, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 20, 2020 | SNEA | SU-EXAMINER'S AMENDMENT WRITTEN | — |
| Aug 18, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 18, 2020 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Aug 18, 2020 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Aug 18, 2020 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jul 28, 2020 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Jul 15, 2020 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Jul 10, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 7, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jun 25, 2020 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Feb 27, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 27, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 27, 2020 | CNFR | SU - FINAL REFUSAL - WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 8, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 6, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 6, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 31, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 31, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 31, 2019 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 24, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 23, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 23, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 21, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 21, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 28, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2019 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 27, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 27, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 14, 2019 | IUAF | USE AMENDMENT FILED | — |
| Jun 14, 2019 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jan 29, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 25, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 25, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 25, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 31, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 27, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 27, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 27, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 30, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 5, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 5, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 15, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 20, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 20, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 20, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 20, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 20, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 4, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 4, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 2, 2017 | ALIE | ASSIGNED TO LIE | — |
| Sep 22, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 21, 2017 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Sep 21, 2017 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Sep 21, 2017 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Sep 21, 2017 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Sep 5, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 10, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 8, 2017 | NWAP | NEW APPLICATION ENTERED | — |